Drug repurposing and adverse event prediction using high‐throughput literature analysis
- 16 February 2011
- journal article
- review article
- Published by Wiley in Wires Systems Biology and Medicine
- Vol. 3 (3), 323-334
- https://doi.org/10.1002/wsbm.147
Abstract
Drug repurposing is the process of using existing drugs in indications other than the ones they were originally designed for. It is an area of significant recent activity due to the mounting costs of traditional drug development and scarcity of new chemical entities brought to the market by bio‐pharmaceutical companies. By selecting drugs that already satisfy basic toxicity, ADME and related criteria, drug repurposing promises to deliver significant value at reduced cost and in dramatically shorter time frames than is normally the case for the drug development process. The same process that results in drug repurposing can also be used for the prediction of adverse events of known or novel drugs. The analytics method is based on the description of the mechanism of action of a drug, which is then compared to the molecular mechanisms underlying all known adverse events. This review will focus on those approaches to drug repurposing and adverse event prediction that are based on the biomedical literature. Such approaches typically begin with an analysis of the literature and aim to reveal indirect relationships among seemingly unconnected biomedical entities such as genes, signaling pathways, physiological processes, and diseases. Networks of associations of these entities allow the uncovering of the molecular mechanisms underlying a disease, better understanding of the biological effects of a drug and the evaluation of its benefit/risk profile. In silico results can be tested in relevant cellular and animal models and, eventually, in clinical trials. WIREs Syst Biol Med 2011 3 323–334 DOI: 10.1002/wsbm.147 For further resources related to this article, please visit the WIREs websiteKeywords
This publication has 63 references indexed in Scilit:
- STITCH 2: an interaction network database for small molecules and proteinsNucleic Acids Research, 2009
- Comparative Toxicogenomics Database: a knowledgebase and discovery tool for chemical-gene-disease networksNucleic Acids Research, 2008
- SuperTarget and Matador: resources for exploring drug-target relationshipsNucleic Acids Research, 2007
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Literature mining for the biologist: from information retrieval to biological discoveryNature Reviews Genetics, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Systems Biology: A Brief OverviewScience, 2002
- The Protein Data BankNucleic Acids Research, 2000
- Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective studyThe American Journal of Medicine, 1989